Table 2 Univariate and multivariate analyses of mitral valve dysfunctions
Univariate | Multivariate | ||
|---|---|---|---|
p value | Hazard ratio (95% CI) | p value | |
Preoperative factors | |||
Age | 0.340 | ||
Female gender | 0.191 | ||
NYHA functional class > 2 | 0.195 | 2.88 (0.83–10.05) | 0.096 |
Hypertension | 0.228 | ||
Diabetes mellitus | 0.119 | ||
History of thromboembolic events | 0.758 | ||
Creatinine, mg/dL | 0.393 | ||
Dialysis | 0.286 | ||
Preoperative atrial fibrillation | 0.945 | ||
Rheumatic etiology of mitral valve vs. Non-Rheumatic | 0.006 | 3.88 (1.60–9.39) | 0.003 |
Aortic valve lesion | 0.869 | ||
LV ejection fraction, % | 0.127 | ||
LV end-systolic dimension, mm | 0.066 | ||
LV end-diastolic dimension, mm | 0.174 | ||
Significant pulmonary hypertension | 0.930 | ||
Operative factors | |||
Aortic valve type | 0.653 | ||
Tricuspid annuloplasty | 0.624 | ||
Maze procedure for AF | 0.651 | ||